Researchers have discovered a new weight loss strategy that involves using oral nanotherapy to reduce fat absorption in the small intestine. This breakthrough approach involves nanoparticles containing siRNAs that regulate gene expression in the small intestine, specifically targeting the SOAT2 gene. In studies on mice, this nanotherapy was shown to decrease fat absorption and weight gain even on a high-fat diet. The researchers believe that this non-invasive and relatively safe approach has the potential to revolutionize obesity management. Further testing will be conducted in larger animal models before moving on to human trials.
Source link